Letter to the editor: Acquired deficiency of functional C1-esterase inhibitor in HIV type 1-infected patients

AIDS Research and Human Retroviruses

Volumn 13, Issue 10, 1997, Pages 813-814

  Gerenčer, Marijan ^a   Burek, Vitomir ^b   Barrett, Noel P ^a   Dorner, Friedrich ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Croatia   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME DEFICIENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; IMMUNOLOGY;

CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COMPLEMENT ACTIVATION; COMPLEMENT C1 INACTIVATOR PROTEINS; HIV INFECTIONS; HIV-1; HUMANS;

EID: 0031178725     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.813     Document Type: Letter

References (7)

1. Oltvai ZN, Wong CC, Atkinson JP, and Tung KSK: Cl-inhibitor deficiency: Molecular and immunologic basis of hereditary and acquired angioedema. Lab Invest 1991;65:381-388.
2. Senaldi G, Peakman M, McManus T, Davies ET, Tee DEH, and Vergani D: Activation of the complement system in human immunodeficiency virus infection: Relevance of the classical pathway to pathogenesis and disease severity. J Infect Dis 1990;162:1227-1232.
3. Stoiber H, Ebenbichler C, Schneider R, Janatova J, and Dierich MP: Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS 1995;9:19-26.
4. Liszewski MK, Farries TC, Lublin DM, Rooney IA, and Atkinson JP: Control of the complement system. Adv Immunol 1996;61:201-283.
5. Daniel V, Süsal C, Weimer R, Zipperle S, Kröpelin M, Zimmermann R, Huth-Kühne A, and Opelz G: Sequential occurrence of IgM, IgM/IgG and gp120 IgM/IgG complement complexes on CD4+ blood lymphocytes depletion in HIV+ hemophilia patients: Results of a 10-year study. Immunol Lett 1995;47:97-102.
6. Nuijens JH, Eereburg-Belmer AJM, Huijbregts CCM, Schreuder WO, Felt-Bersma RJF, Abbink JJ, Thijs LG, and Hack CE: Proteolytic inactivation of plasma Cl-inhibitor in sepsis. J Clin Invest 1989;84:443-450.
7. Carpenter CB, Ruddy S, Shekadeh IH, Muller-Eberhard HJ, Merril JP, and Austen KF: Complement metabolism in man: Hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary angioedema (HAE). J Clin Invest 1969;48:1495-1502.